PL332278A1 - Novel methods - Google Patents

Novel methods

Info

Publication number
PL332278A1
PL332278A1 PL97332278A PL33227897A PL332278A1 PL 332278 A1 PL332278 A1 PL 332278A1 PL 97332278 A PL97332278 A PL 97332278A PL 33227897 A PL33227897 A PL 33227897A PL 332278 A1 PL332278 A1 PL 332278A1
Authority
PL
Poland
Prior art keywords
novel methods
novel
methods
Prior art date
Application number
PL97332278A
Other languages
English (en)
Inventor
Jeremy N Bradbeer
Maxine Gowen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL332278A1 publication Critical patent/PL332278A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
PL97332278A 1996-09-06 1997-09-03 Novel methods PL332278A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
PL332278A1 true PL332278A1 (en) 1999-08-30

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
PL97332038A PL332038A1 (en) 1996-09-06 1997-09-03 Method of treating postmenopausal diseases including osteoporosis
PL97332278A PL332278A1 (en) 1996-09-06 1997-09-03 Novel methods

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL97332038A PL332038A1 (en) 1996-09-06 1997-09-03 Method of treating postmenopausal diseases including osteoporosis

Country Status (16)

Country Link
EP (2) EP0929216A4 (de)
JP (2) JP2002515047A (de)
KR (2) KR20000068472A (de)
CN (2) CN1236299A (de)
AR (1) AR008155A1 (de)
AU (2) AU4247397A (de)
BR (2) BR9711676A (de)
CA (2) CA2264943A1 (de)
CO (2) CO4920218A1 (de)
CZ (1) CZ76699A3 (de)
IL (1) IL128645A0 (de)
NO (2) NO991096L (de)
PL (2) PL332038A1 (de)
TR (2) TR199900504T2 (de)
TW (1) TW411273B (de)
WO (2) WO1998009519A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5749998A (en) * 1997-02-11 1998-08-26 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (de) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifenderivate
ATE162516T1 (de) * 1992-09-15 1998-02-15 Merrell Pharma Inc Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren
WO1996040098A2 (en) * 1995-06-07 1996-12-19 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
NO991097D0 (no) 1999-03-05
KR20000068472A (ko) 2000-11-25
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
CZ76699A3 (cs) 1999-08-11
TR199900506T2 (xx) 1999-07-21
EP0929216A1 (de) 1999-07-21
PL332038A1 (en) 1999-08-16
CO4920218A1 (es) 2000-05-29
CN1236299A (zh) 1999-11-24
IL128645A0 (en) 2000-01-31
NO991096D0 (no) 1999-03-05
NO991097L (no) 1999-03-05
WO1998009519A1 (en) 1998-03-12
TW411273B (en) 2000-11-11
EP0927029A1 (de) 1999-07-07
AU4247397A (en) 1998-03-26
CO5070658A1 (es) 2001-08-28
AR008155A1 (es) 1999-12-09
NO991096L (no) 1999-03-05
KR20000068473A (ko) 2000-11-25
CN1236313A (zh) 1999-11-24
BR9711676A (pt) 1999-08-24
CA2264775A1 (en) 1998-03-12
JP2002515046A (ja) 2002-05-21
EP0927029A4 (de) 2001-06-13
WO1998009619A1 (en) 1998-03-12
CA2264943A1 (en) 1998-03-12
TR199900504T2 (xx) 1999-06-21
EP0929216A4 (de) 2001-04-04
JP2002515047A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
DE69729315D1 (en) Aminopyrazolderivate
GB9600464D0 (en) Novel method
SG60040A1 (en) Novel heterroaryl-oxazolidinones
PL329032A1 (en) Quinoxalynodiones
GB9722594D0 (en) Methods
DE69722552D1 (en) Photolithographisches gerät
EP0895545A4 (de) Protein traf6
PL332278A1 (en) Novel methods
GB9609722D0 (en) Novel method
GB9604465D0 (en) Novel method
GB9621741D0 (en) Tee-cushion
PL328019A1 (en) Novel phenantidines
ZA977997B (en) Novel methods
GB9614419D0 (en) Novel compositikon
SI0923568T1 (en) Novel benzofuran-4-carboxamides
GB9607526D0 (en) Novel method
GB9622748D0 (en) Novel method
GB9622865D0 (en) Novel method
GB9622866D0 (en) Novel method
GB9622867D0 (en) Novel method
GB9622868D0 (en) Novel method
GB9622869D0 (en) Novel method
GB9600463D0 (en) Novel method
GB9622850D0 (en) Novel method
GB9622870D0 (en) Novel method